We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Regeneron has inked an agreement with HHS to manufacture and study two antibody therapies for the prevention and treatment of Middle East Respiratory Syndrome. Read More
The FDA has asked for more information on the pen injector device used in Sanofi and Zealand Pharma's IGlarLixi combination product for diabetes, and extended its review by three months, hurting its chances to be the first product of its kind on the U.S. market. Read More